AL
PFE icon

Appaloosa LP’s Pfizer PFE Stock Holding History

Appaloosa LP’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,184,134
Closed -$103M – 65
2017
Q1 		$103M Sell
3,184,134
-1,885,606
-37% -$59.5M 1.7% 21
2016
Q4 		$156M Buy
+5,069,740
New +$155M 2.77% 10
2016
Q2 		– Sell
-2,647,912
Closed -$74.5M – 44
2016
Q1 		$74.5M Buy
+2,647,912
New +$75.6M 1.32% 27

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Appaloosa LP's PFE Position: Q2 2017 in Review

Appaloosa LP sold out of Pfizer (PFE) in Q2 2017, closing a stake of 3,184,134 shares — an estimated $103M sold.

Appaloosa LP first reported a position in PFE in Q1 2016 and held it in 3 quarters. The position peaked at $156M in Q4 2016. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • Appaloosa LP reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
  • Appaloosa LP sold 3,184,134 Pfizer shares in Q2 2017, an estimated $103M.
  • Appaloosa LP first reported a position in Pfizer in Q1 2016 and held it in 3 quarters.
  • Appaloosa LP's Pfizer position peaked at $156M in Q4 2016.
  • 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Appaloosa LP's 13F filing for Q2 2017, filed 14 Aug 2017.